JP MORGAN/CALL/BECTON DICKINSON AND CO./245/0.1/17.01.25 Stock

Warrant

DE000JL1KNP3

Real-time Bid/Ask 10:13:49 2024-06-17 EDT
1.91 EUR / 1.94 EUR +0.26% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./245/0.1/17.01.25
Current month+9.09%
1 month-19.33%
Date Price Change
24-06-17 2.07 +7.81%
24-06-14 1.92 -5.88%
24-06-13 2.04 -3.77%
24-06-12 2.12 -10.17%
24-06-11 2.36 +0.43%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 03:17 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNP
ISINDE000JL1KNP3
Date issued 2023-04-05
Strike 245 $
Maturity 2025-01-17 (214 Days)
Parity 10 : 1
Emission price 3.57
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.96
Lowest since issue 1.56
Spread 0.03
Spread %1.51%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus